Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection

References

• MoroniMAntinoriSHIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy eraAIDS200317Suppl 1S51S6412870531
   PubMedGoogle Scholar
• AtluriVSKanthikeelSPReddyPVYndartANairMPHuman synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND)PLoS One201384e6139923620748
   PubMed Web of Science ®Google Scholar
• Gonzalez-ScaranoFMartin-GarciaJThe neuropathogenesis of AIDSNat Rev Immunol200551698115630430
   PubMed Web of Science ®Google Scholar
• Alvarez LosadaSCanto-NoguesCMunoz-FernandezMAA new possible mechanism of human immunodeficiency virus type 1 infection of neural cellsNeurobiol Dis200211346947812586555
   PubMedGoogle Scholar
• HarouseJMCollmanRGGonzalez-ScaranoFHuman immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′ sulfo-galactosyl ceramide-positive cell lineJ Virol19956912738373907494242
   PubMedGoogle Scholar
• AtluriVSPilakka-KanthikeelSSamikkannuTVorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorderMol Brain201473724886748
   PubMed Web of Science ®Google Scholar
• MasliahEDeTeresaRMMalloryMEHansenLAChanges in pathological findings at autopsy in AIDS cases for the last 15 yearsAIDS2000141697410714569
   PubMed Web of Science ®Google Scholar
• GrayFAdle-BiassetteHChretienFLorin de la GrandmaisonGForceGKeohaneCNeuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatmentsClin Neuropathol200120414615511495003
   PubMed Web of Science ®Google Scholar
• AylwardEHHendererJDMcArthurJCReduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimagingNeurology19934310209921048413973
   PubMed Web of Science ®Google Scholar
• BergerJRArendtGHIV dementia: the role of the basal ganglia and dopaminergic systemsJ Psychopharmacol200014321422111106299
   PubMed Web of Science ®Google Scholar
• StamenkovicIExtracellular matrix remodelling: the role of matrix metalloproteinasesJ Pathol2003200444846412845612
   PubMed Web of Science ®Google Scholar
• MurphyGNagaseHProgress in matrix metalloproteinase researchMol Aspects Med200829529030818619669
   PubMed Web of Science ®Google Scholar
• GillSEParksWCMetalloproteinases and their inhibitors: regulators of wound healingInt J Biochem Cell Biol2008406–71334134718083622
   PubMed Web of Science ®Google Scholar
• RadiskyESRadiskyDCMatrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancerJ Mammary Gland Biol Neoplasia201015220121220440544
   PubMed Web of Science ®Google Scholar
• BrewKDinakarpandianDNagaseHTissue inhibitors of metalloproteinases: evolution, structure and functionBiochim Biophys Acta200014771–226728310708863
   PubMed Web of Science ®Google Scholar
• MurphyGTissue inhibitors of metalloproteinasesGenome Biol2011121123322078297
   PubMed Web of Science ®Google Scholar
• BermanNEJMarcarioJKYongCMicroglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changesNeurobiol Dis19996648649810600404
   PubMedGoogle Scholar
• LorenzlSAlbersDSRelkinNIncreased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s diseaseNeurochem Int200343319119612689599
   PubMed Web of Science ®Google Scholar
• MuroskiMERoycikMDNewcomerRGMatrix metalloprotei-nase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosisCurr Pharm Biotechnol200891344618289055
   PubMed Web of Science ®Google Scholar
• BÉLiveauRDelbecchiLBeaulieuEExpression of matrix metalloproteinases and their inhibitors in human brain tumorsAnn N Y Acad Sci1999886123623910667228
   PubMedGoogle Scholar
• YinPYangLZhouHYSunRPMatrix metalloproteinase-9 may be a potential therapeutic target in epilepsyMed Hypotheses201176218418620888701
   PubMed Web of Science ®Google Scholar
• JourquinJTremblayEDécanisNNeuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainateEur J Neurosci20031861507151714511330
   PubMed Web of Science ®Google Scholar
• CoussensLMFingletonBMatrisianLMMatrix metalloproteinase inhibitors and cancer: trials and tribulationsScience200229555642387239211923519
   PubMed Web of Science ®Google Scholar
• TurkBTargeting proteases: successes, failures and future prospectsNat Rev Drug Discov20065978579916955069
   PubMed Web of Science ®Google Scholar
• BurragePSBrinckerhoffCEMolecular targets in osteoarthritis: metalloproteinases and their inhibitorsCurr Drug Targets20078229330317305507
   PubMed Web of Science ®Google Scholar
• FingletonBMMPs as therapeutic targets – still a viable option?Semin Cell Dev Biol2008191616817693104
   PubMed Web of Science ®Google Scholar
• Van den SteenPEDuboisBNelissenIRuddPMDwekRAOpdenakkerGBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)Crit Rev Biochem Mol Biol200237637553612540195
   PubMed Web of Science ®Google Scholar
• Ashutosh ChaoCBorgmannKBrewKGhorpadeATissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: mechanisms and relevance to HIV-1-associated dementiaCell Death Dis201236e33222739984
   PubMedGoogle Scholar
• ChaturvediMMolinoYSreedharBKhrestchatiskyMKaczmarekLTissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrierInt J Nanomedicine2014957558824531257
   PubMed Web of Science ®Google Scholar
• PardridgeWMBlood-brain barrier deliveryDrug Discov Today2007121–2546117198973
   PubMed Web of Science ®Google Scholar
• MandelRJGageFHClevengerDGSprattSKSnyderROLeffSENerve growth factor expressed in the medial septum followingin vivo-gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degenerationExp Neurol1999155159649918705
   PubMedGoogle Scholar
• BlitsBOudegaMBoerGJBartlett BungeMVerhaagenJAdeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb functionNeuroscience2003118127128112676157
   PubMedGoogle Scholar
• WilliamsLRVaronSPetersonGMContinuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transectionProc Natl Acad Sci U S A19868323923192353466184
   PubMedGoogle Scholar
• ThoenenHSendtnerMNeurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approachesNat Neurosci20025Suppl1046105012403983
   PubMed Web of Science ®Google Scholar
• AlexiouCSchmidRJJurgonsRTargeting cancer cells: magnetic nanoparticles as drug carriersEur Biophys J200635544645016447039
   PubMed Web of Science ®Google Scholar
• LübbeASBergemannCHuhntWPreclinical experiences with magnetic drug targeting: tolerance and efficacyCancer Res19965620469447018840986
   PubMed Web of Science ®Google Scholar
• NairMJayantRDKaushikASagarVGetting into the brain: potential of nanotechnology in the management of neuroAIDSAdv Drug Deliv Rev201610320221726944096
   PubMed Web of Science ®Google Scholar
• JayantRNairMNanotechnology for the treatment of NeuroAIDSJ Nanomed Res20163100047
   Google Scholar
• SagarVPilakka-KanthikeelSAtluriVSTherapeutical neurotargeting via magnetic nanocarrier: implications to opiate-induced neuropathogenesis and neuroAIDSJ Biomed Nanotechnol201511101722173326502636
   PubMed Web of Science ®Google Scholar
• DingHSagarVAgudeloMEnhanced blood-brain barrier transmigration using a novel Transferrin-embedded fluorescent magneto-liposome nanoformulationNanotechnology Epub201419
   Google Scholar
• NairMGuduruRLiangPHongJSagarVKhizroevSExternally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriersNat Commun20134170723591874
   PubMed Web of Science ®Google Scholar
• KaushikAJayantRDNikkhah-MoshaieRMagnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriersSci Rep201662530927143580
   PubMed Web of Science ®Google Scholar
• JayantRDAtluriVSAgudeloMSagarVKaushikANairMSustained-release nanoART formulation for the treatment of neuroAIDSInt J Nanomedicine2015101077109325709433
   PubMed Web of Science ®Google Scholar
• PersidskyYStinsMWayDA model for monocyte migration through the blood-brain barrier during HIV-1 encephalitisJ Immunol19971587349935109120312
   PubMedGoogle Scholar
• TodukaYToyookaTIbukiYFlow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence correlation with genotoxicityEnviron Sci Technol201246147629763622703531
   PubMed Web of Science ®Google Scholar
• KurapatiKRAtluriVSSamikkannuTNairMPAshwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND)PLoS One2013810e7762424147038
   PubMed Web of Science ®Google Scholar
• AgudeloMGandhiNSaiyedZEffects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA)Alcohol Clin Exp Res20113581550155621447001
   PubMed Web of Science ®Google Scholar
• ZhangYWangMLiHAccumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disordersBrain Res2012145811122554480
   PubMed Web of Science ®Google Scholar
• LouboutinJPStrayerDRole of oxidative stress in HIV-1-associated neurocognitive disorder and protection by gene delivery of antioxidant enzymesAntioxidants (Basel)20143477079726785240
   PubMedGoogle Scholar
• TejimaEGuoSMurataYNeuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1J Neurotrauma200926111935194119469687
   PubMedGoogle Scholar
• DhawanSWeeksBSSoderlandCHIV-1 infection alters monocyte interactions with human microvascular endothelial cellsJ Immunol199515414224327527819
   PubMed Web of Science ®Google Scholar
• SuryadevaraRHolterSBorgmannKRegulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementiaGlia2003441475612951656
   PubMedGoogle Scholar
• JourquinJTremblayEBernardATissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memoryEur J Neurosci200522102569257816307599
   PubMedGoogle Scholar
• YongVWPowerCForsythPEdwardsDRMetalloproteinases in biology and pathology of the nervous systemNat Rev Neurosci20012750251111433375
   PubMed Web of Science ®Google Scholar
• NediviEHevroniDNaotDIsraeliDCitriYNumerous candidate plasticity-related genes revealed by differential cDNA cloningNature199336364317187228515813
   PubMedGoogle Scholar
• Pilakka-KanthikeelSAtluriVSRSagarVSaxenaSKNairMTargeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuroprotection using magnetic nano carriers: an in-vitro studyPLoS One201384e6224123653680
   PubMed Web of Science ®Google Scholar
• MastroianniCMLiuzziGMMatrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategiesTrends Mol Med2007131144945918029231
   PubMedGoogle Scholar
• HudsonLLiuJNathADetection of the human immunodeficiency virus regulatory protein tat in CNS tissuesJ Neurovirol20006214515510822328
   PubMed Web of Science ®Google Scholar
• LatronicoTLiuzziGMRiccioPAntiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patientsAIDS200721667768417413688
   PubMedGoogle Scholar
• NelAXiaTMädlerLLiNToxic potential of materials at the nano-levelScience2006311576162262716456071
   PubMed Web of Science ®Google Scholar
• DianaVBossolascoPMoscatelliDSilaniVCovaLDose dependent side effect of superparamagnetic iron oxide nanoparticle labeling on cell motility in two fetal stem cell populationsPLoS One2013811e7843524244310
   PubMed Web of Science ®Google Scholar
• VelazquezIPlaudMWojnaVSkolaskyRLaspiurJPMelendezLMAntioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairmentJ Neuroimmunol20092061–210611119101040
   PubMedGoogle Scholar
• VivianiBCorsiniEBinagliaMGalliCLMarinovichMReactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitroNeuroscience20011071515811744246
   PubMedGoogle Scholar